Speaker Disclosure
Dr. Merlini is participating in a phase I-II trial of bortezomib in AL amyloidosis sponsored by Millennium Pharmaceuticals - Johnson & Johnson
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.